验证数据展示
经过测试的应用
Positive IF/ICC detected in | HUVEC cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:125-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
82993-5-RR targets Endoglin/CD105 in IF/ICC, ELISA applications and shows reactivity with Human samples.
经测试应用 | IF/ICC, ELISA Application Description |
经测试反应性 | Human |
免疫原 | Fusion Protein 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Recombinant |
产品类型 | Antibody |
全称 | endoglin |
别名 | CD105, END, Endoglin, ENG, HHT1, ORW, ORW1, 230047E8 |
计算分子量 | 71 kDa |
GenBank蛋白编号 | BC014271 |
基因名称 | CD105 |
Gene ID (NCBI) | 2022 |
RRID | AB_3670741 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Protein A purfication |
UNIPROT ID | P17813 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
Endoglin (ENG, CD105) is a homodimeric cell membrane glycoprotein of 180 kDa, composed of disulphide-linked subunits of 95 kDa. Endoglin is a proliferation-associated and hypoxia-inducible protein mainly expressed on vascular endothelial cells. It acts as an accessory receptor for transforming growth factor beta (TFG-β) and is involved in vascular development and remodelling. The important role of Endoglin in angiogenesis and in tumor progression makes it an ideal target for antiangiogenic therapy and a good marker for tumor prognosis. (PMID: 1326540; 14528280; 21737653; 12773481)
实验方案
Product Specific Protocols | |
---|---|
IF protocol for Endoglin/CD105 antibody 82993-5-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |